Theraclone Sciences' Grant - III Round

Theraclone Sciences raised a round of funding on January 22, 2010. Investors include Qualifying Therapeutic Discovery Project.

Theraclone Sciences, formerly Spaltudaq, is a biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The companys technolo…

Articles about Theraclone Sciences' Grant - III Round: